Founded by Morten Rønn Petersen, DVM, PhD, and Professor Anders Miki Bojesen, DVM, PhD, bActivate offers innovative products and services based on their extensive experience and research in bacterial endometritis. The concept behind bActivate was born from their discovery that Streptococcus equi subspecies zooepidemicus (S. zoo) can enter a non-active/dormant state in the endometrium of chronically infected mares.

By infusing a special bacterial growth medium into the uterus, bActivate induces active growth of S. zoo, which allows for enhanced diagnosis and treatment efficacy. Field studies using bActivate have shown improved diagnosis and treatment outcomes, leading to enhanced mare fertility.

With the goal of improving reproductive efficiency in horses, bActivate aims to benefit both horses and humans. To explore their range of products, visit the bActivate online shop. Additionally, bActivate is distributed by reputable partners in Europe, the USA, Australia, Denmark, Ireland, and other locations, ensuring convenient access to their innovative solutions.

Please note that terms and conditions apply for bActivate products, which are sold and produced by Bojesen and Petersen Biotech ApS